Zobrazeno 1 - 10
of 11
pro vyhledávání: '"W A Van Deijk"'
Publikováno v:
The Netherlands Journal of Medicine. 48:133-139
We describe four patients with a mature T-cell disorder. These four specific entities belong to a group formerly called “T-cell chronic lymphocytic leukaemia” (T-CLL). Nowadays we understand that these chronic T-cell lymphoproliferative disorders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64c585855155a100dd3014a9a2eeb324
https://doi.org/10.1016/s0300-2977(96)80016-7
https://doi.org/10.1016/s0300-2977(96)80016-7
Autor:
John J. Hermans, P. W. Wijermans, J. C. Kluin-Nelemans, Philippus Kluin, Evert M. Noordijk, W A Van Deijk, S. Snijder, E. Maartense
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 9(11)
BACKGROUND To compare characteristics, treatment and outcome of patients > or = 70 years with patients < 70 years in a population-based non-Hodgkin's lymphoma (NHL) registry. PATIENTS AND METHODS All new patients with NHL (n = 1168) in a geographical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e94987e6e9a988ca5ac4d76350ddae84
https://pubmed.ncbi.nlm.nih.gov/9862053
https://pubmed.ncbi.nlm.nih.gov/9862053
Publikováno v:
The Netherlands journal of medicine. 48(4)
We describe four patients with a mature T-cell disorder. These four specific entities belong to a group formerly called "T-cell chronic lymphocytic leukaemia" (T-CLL). Nowadays we understand that these chronic T-cell lymphoproliferative disorders con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::98b7e26ebef067aa577904c00a7469c8
https://pubmed.ncbi.nlm.nih.gov/8999360
https://pubmed.ncbi.nlm.nih.gov/8999360
Autor:
Johanna Kluin-Nelemans, J.H.J.M. van Krieken, Jo Hermans, G A Velders, J B Rahder, M. H. H. Kramer, W A Van Deijk, C. J. De Boer, Ph. M. Kluin, Ed Schuuring, Evert M. Noordijk
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 14(4)
PURPOSE From a population-based non-Hodgkin's lymphoma (NHL) registry, 41 patients with mantle cell lymphoma (MCL) -- a recently defined distinct B-cell NHL -- were selected and compared with patients with low- or intermediate-grade NHL from the same
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73be61c44bec50ec1d26ca492b49b691
https://pubmed.ncbi.nlm.nih.gov/8648383
https://pubmed.ncbi.nlm.nih.gov/8648383
Publikováno v:
The Netherlands journal of medicine. 45(3)
A 36-year-old woman with a dedifferentiated liposarcoma is described who had suffered from Sweet syndrome in the past. From the literature a relationship between this syndrome and malignancy is known to exist. However, the combination of Sweet syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1cdb89aeb054ffbf35a420f1b8a15cea
https://pubmed.ncbi.nlm.nih.gov/7969662
https://pubmed.ncbi.nlm.nih.gov/7969662
Autor:
A. de Graeff, S. van der Vegt, Jan H. Schornagel, Jaap Verweij, A. Dullemond-Westland, W. A. van Deijk, W.W. ten Bokkel Huinink
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 3(7)
A phase II trial of the new antifolate edatrexate (10-ethyl-10-deaza-aminopterin) was performed in thirty-eight patients with metastatic breast cancer who had never received chemotherapy. Edatrexate was administered as a weekly intravenous bolus inje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::656dfdad8dc4014ef6fd1ce795d0324e
https://pubmed.ncbi.nlm.nih.gov/1498076
https://pubmed.ncbi.nlm.nih.gov/1498076
Publikováno v:
European Journal of Gastroenterology & Hepatology. 11:A61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::087dfcbd7f5ac0cfb7f36467fa8d3a7b
https://doi.org/10.1097/00042737-199912000-00165
https://doi.org/10.1097/00042737-199912000-00165
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 13:198-200
A preliminary report suggests a correlation between metastatic prostate cancer and increased plasma factor Vila levels. Prostate cancer without metastases and prostate hypertrophy showed no clear pattern in factor VIla. Further investigations concern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e43524ab45adc76e58d34156f4dceca
https://doi.org/10.1159/000214727
https://doi.org/10.1159/000214727
Publikováno v:
Haemostasis, 13(3), 192-197. S. Karger AG
Scopus-Elsevier
Scopus-Elsevier
A coagulation assay is described that allows the measurement of the degree of activation of factor VII in circulating blood. The test is based on the use of both bovine and human brain thromboplastin, together with an artificial factor VII-deficient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce665761e3d4e50ad6505d1bdd641da
https://cris.maastrichtuniversity.nl/en/publications/611c9616-85a1-43f7-9a31-8a193a3512e4
https://cris.maastrichtuniversity.nl/en/publications/611c9616-85a1-43f7-9a31-8a193a3512e4
Publikováno v:
The Netherlands journal of medicine. 22(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fb30d7e0e7ddeb7e63ced52cc6cabb28
https://pubmed.ncbi.nlm.nih.gov/316501
https://pubmed.ncbi.nlm.nih.gov/316501